Docosahexaenoic Acid Signalolipidomics in Nutrition: Significance in Aging, Neuroinflammation, Macular Degeneration, Alzheimer's, and Other Neurodegenerative Diseases
- 21 August 2011
- journal article
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 31 (1), 321-351
- https://doi.org/10.1146/annurev.nutr.012809.104635
Abstract
Essential polyunsaturated fatty acids (PUFAs) are critical nutritional lipids that must be obtained from the diet to sustain homeostasis. Omega-3 and -6 PUFAs are key components of biomembranes and play important roles in cell integrity, development, maintenance, and function. The essential omega-3 fatty acid family member docosahexaenoic acid (DHA) is avidly retained and uniquely concentrated in the nervous system, particularly in photoreceptors and synaptic membranes. DHA plays a key role in vision, neuroprotection, successful aging, memory, and other functions. In addition, DHA displays anti-inflammatory and inflammatory resolving properties in contrast to the proinflammatory actions of several members of the omega-6 PUFAs family. This review discusses DHA signalolipidomics, comprising the cellular/tissue organization of DHA uptake, its distribution among cellular compartments, the organization and function of membrane domains rich in DHA-containing phospholipids, and the cellular and molecular events revealed by the uncovering of signaling pathways regulated by DHA and docosanoids, the DHA-derived bioactive lipids, which include neuroprotectin D1 (NPD1), a novel DHA-derived stereoselective mediator. NPD1 synthesis agonists include neurotrophins and oxidative stress; NPD1 elicits potent anti-inflammatory actions and prohomeostatic bioactivity, is anti-angiogenic, promotes corneal nerve regeneration, and induces cell survival. In the context of DHA signalolipidomics, this review highlights aging and the evolving studies on the significance of DHA in Alzheimer's disease, macular degeneration, Parkinson's disease, and other brain disorders. DHA signalolipidomics in the nervous system offers emerging targets for pharmaceutical intervention and clinical translation.Keywords
This publication has 153 references indexed in Scilit:
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2010
- Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasisProstaglandins, Leukotrienes & Essential Fatty Acids, 2010
- PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosisExperimental Eye Research, 2010
- Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophilsProstaglandins, Leukotrienes & Essential Fatty Acids, 2010
- Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?Prostaglandins, Leukotrienes & Essential Fatty Acids, 2009
- Serum lutein concentrations in healthy term infants fed human milk or infant formula with luteinEuropean Journal of Nutrition, 2009
- Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's diseaseNeuroscience Research, 2008
- Docosahexaenoic acid (DHA) and hepatic gene transcriptionChemistry and Physics of Lipids, 2008
- Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liverProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD StudyArchives of Neurology, 2006